Literature DB >> 23062994

Molecular etiology of second primary tumors in contralateral tonsils of human papillomavirus-associated index tonsillar carcinomas.

Andrew W Joseph1, Takenori Ogawa, Justin A Bishop, Sofia Lyford-Pike, Xiaofei Chang, Timothy H Phelps, William H Westra, Sara I Pai.   

Abstract

OBJECTIVES: For patients with tobacco-related head and neck squamous cell carcinoma (HNSCC), the occurrence of a second primary tumor (SPT) is an ominous development that is attributed to a field cancerization effect and portends a poor clinical outcome. The goal of this study was to determine whether patients with human papillomavirus (HPV)-related index tonsillar carcinomas can also develop SPTs in the contralateral tonsil, and to discern the molecular etiology of HPV-related tumor multifocality.
MATERIALS AND METHODS: The surgical pathology archives of The Johns Hopkins Hospital were searched for all patients with primary HPV-related tonsillar squamous cell carcinoma who developed a synchronous or metachronous carcinoma in the contralateral tonsil. The HPV-16 E6 exon was sequenced from each independent cancer site to determine whether the tumor pairs harbored the same or a different HPV-16 variant.
RESULTS: Four patients with bilateral HPV-related tonsillar carcinomas were identified. In every case, the HPV DNA sequences derived from the index tumor and corresponding SPT were 100% concordant, indicating that the index and SPTs were caused by the same HPV-16 variant.
CONCLUSION: For the small subset of patients with tonsillar carcinomas who develop SPTs in the contralateral tonsil, the index case and the SPT consistently harbored the same HPV variant. This finding suggests that HPV-related tumor multi-focality can be attributed either to independent inoculation events by the same virus, or by migration of HPV-infected cells from a single inoculation site to other regions of Waldeyer's ring.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062994      PMCID: PMC3548989          DOI: 10.1016/j.oraloncology.2012.09.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source.

Authors:  W M Koch; N Bhatti; M F Williams; D W Eisele
Journal:  Otolaryngol Head Neck Surg       Date:  2001-03       Impact factor: 3.497

2.  HPV16 transmission between a couple with HPV-related head and neck cancer.

Authors:  Robert Haddad; Christopher Crum; Zigui Chen; Jeffrey Krane; Marshall Posner; Yi Li; Robert Burk
Journal:  Oral Oncol       Date:  2007-12-03       Impact factor: 5.337

3.  High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.

Authors:  Lisa Licitra; Federica Perrone; Paolo Bossi; Simona Suardi; Luigi Mariani; Raffaella Artusi; Maria Oggionni; Chiara Rossini; Giulio Cantù; Massimo Squadrelli; Pasquale Quattrone; Laura D Locati; Cristiana Bergamini; Patrizia Olmi; Marco A Pierotti; Silvana Pilotti
Journal:  J Clin Oncol       Date:  2006-12-20       Impact factor: 44.544

4.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.

Authors:  C M Wheeler; T Yamada; A Hildesheim; S A Jenison
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

6.  Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.

Authors:  W K Hong; S M Lippman; L M Itri; D D Karp; J S Lee; R M Byers; S P Schantz; A M Kramer; R Lotan; L J Peters
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

7.  Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile.

Authors:  Monika Hampl; Nicolas Wentzensen; Svetlana Vinokurova; Magnus von Knebel-Doeberitz; Cristopher Poremba; Hans G Bender; Volkmar Kueppers
Journal:  J Cancer Res Clin Oncol       Date:  2006-11-25       Impact factor: 4.553

8.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

9.  Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.

Authors:  Shu-Chun Chuang; Ghislaine Scelo; Jon M Tonita; Sharon Tamaro; Jon G Jonasson; Erich V Kliewer; Kari Hemminki; Elisabete Weiderpass; Eero Pukkala; Elizabeth Tracey; Soren Friis; Vera Pompe-Kirn; David H Brewster; Carmen Martos; Kee-Seng Chia; Paolo Boffetta; Paul Brennan; Mia Hashibe
Journal:  Int J Cancer       Date:  2008-11-15       Impact factor: 7.396

10.  Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.

Authors:  T Yamada; C M Wheeler; A L Halpern; A C Stewart; A Hildesheim; S A Jenison
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more
  11 in total

1.  Two for the price of one: Prevalence, demographics and treatment implications of multiple HPV mediated Head and Neck Cancers.

Authors:  William Strober; Sachie Shishido; Burton Wood; James S Lewis; Krystle Kuhs; Robert L Ferris; Daniel L Faden
Journal:  Oral Oncol       Date:  2019-11-22       Impact factor: 5.337

2.  Severe prolonged dysphagia following transoral resection of bilateral synchronous tonsillar carcinoma.

Authors:  Alpen B Patel; Michael L Hinni; Taylor R Pollei; Richard E Hayden; Eric J Moore
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-08       Impact factor: 2.503

3.  Surgically treated oropharyngeal cancer: risk factors and tumor characteristics.

Authors:  Philipp Baumeister; Maximilian Reiter; Christian Welz; Sven Becker; Christian Betz; Ulrich Harréus
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-11       Impact factor: 4.553

Review 4.  Targeting minimal residual disease: a path to cure?

Authors:  Marlise R Luskin; Mark A Murakami; Scott R Manalis; David M Weinstock
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

Review 5.  Exploring the roles of HPV16 variants in head and neck squamous cell carcinoma: current challenges and opportunities.

Authors:  Daniela Cochicho; Rui Gil da Costa; Ana Felix
Journal:  Virol J       Date:  2021-11-08       Impact factor: 4.099

6.  Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.

Authors:  Mererid Evans; Robert Newcombe; Alison Fiander; James Powell; Martin Rolles; Selvam Thavaraj; Max Robinson; Ned Powell
Journal:  BMC Cancer       Date:  2013-05-01       Impact factor: 4.430

7.  Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).

Authors:  Yuh-S Jung; Jiwon Lim; Kyu-Won Jung; Junsun Ryu; Young-Joo Won
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

Review 8.  Synchronous bilateral tonsil carcinoma: case presentation and review of the literature.

Authors:  M-N Theodoraki; J A Veit; T K Hoffmann; J Greve
Journal:  Infect Agent Cancer       Date:  2017-06-26       Impact factor: 2.965

9.  Synchronous HPV-Related Cancer of Bilateral Tonsils Detected Using Transoral Endoscopic Examination with Narrow-Band Imaging.

Authors:  Fukuko Shimizu; Kenji Okami; Koji Ebisumoto; Daisuke Maki; Akihiro Sakai; Go Ogura; Naoya Nakamura; Masahiro Iida
Journal:  Case Rep Otolaryngol       Date:  2017-10-12

Review 10.  Current Status of Human Papillomavirus-Related Head and Neck Cancer: From Viral Genome to Patient Care.

Authors:  Haoru Dong; Xinhua Shu; Qiang Xu; Chen Zhu; Andreas M Kaufmann; Zhi-Ming Zheng; Andreas E Albers; Xu Qian
Journal:  Virol Sin       Date:  2021-06-21       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.